CRNX
Price
$53.28
Change
+$7.33 (+15.95%)
Updated
Jan 7, 04:59 PM (EDT)
Capitalization
4.57B
55 days until earnings call
Intraday BUY SELL Signals
RNA
Price
$72.31
Change
-$0.06 (-0.08%)
Updated
Jan 8, 03:43 PM (EDT)
Capitalization
10.9B
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRNX vs RNA

Header iconCRNX vs RNA Comparison
Open Charts CRNX vs RNABanner chart's image
Crinetics Pharmaceuticals
Price$53.28
Change+$7.33 (+15.95%)
Volume$59.44K
Capitalization4.57B
Avidity Biosciences
Price$72.31
Change-$0.06 (-0.08%)
Volume$396
Capitalization10.9B
CRNX vs RNA Comparison Chart in %
CRNX
Daily Signal:
Gain/Loss:
RNA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRNX vs. RNA commentary
Jan 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Hold and RNA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 09, 2026
Stock price -- (CRNX: $53.34 vs. RNA: $72.37)
Brand notoriety: CRNX and RNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 337% vs. RNA: 55%
Market capitalization -- CRNX: $5.06B vs. RNA: $10.9B
CRNX [@Biotechnology] is valued at $5.06B. RNA’s [@Biotechnology] market capitalization is $10.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $122.84B to $0. The average market capitalization across the [@Biotechnology] industry is $2.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileRNA’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • RNA’s FA Score: 0 green, 5 red.
According to our system of comparison, RNA is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 4 TA indicator(s) are bullish while RNA’s TA Score has 4 bullish TA indicator(s).

  • CRNX’s TA Score: 4 bullish, 4 bearish.
  • RNA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RNA is a better buy in the short-term than CRNX.

Price Growth

CRNX (@Biotechnology) experienced а +14.59% price change this week, while RNA (@Biotechnology) price change was +0.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.59%. For the same industry, the average monthly price growth was +0.50%, and the average quarterly price growth was +45.26%.

Reported Earning Dates

CRNX is expected to report earnings on Mar 04, 2026.

RNA is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+4.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNA($10.9B) has a higher market cap than CRNX($4.57B). RNA YTD gains are higher at: 0.333 vs. CRNX (-1.289). CRNX has higher annual earnings (EBITDA): -474.16M vs. RNA (-609.06M). RNA has more cash in the bank: 1.88B vs. CRNX (1.09B). CRNX (49.1M) and RNA (50M) have identical debt. RNA has higher revenues than CRNX: RNA (20.9M) vs CRNX (1.54M).
CRNXRNACRNX / RNA
Capitalization4.57B10.9B42%
EBITDA-474.16M-609.06M78%
Gain YTD-1.2890.333-387%
P/E RatioN/AN/A-
Revenue1.54M20.9M7%
Total Cash1.09B1.88B58%
Total Debt49.1M50M98%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
46
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXRNA
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 4 days ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
76%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signal:
Gain/Loss:
RNA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BSCZ20.860.02
+0.10%
Invesco BulletShares 2035 Corp Bd ETF
XRMI17.97-0.06
-0.33%
Global X S&P 500® Risk Managed Inc ETF
FLCV31.73-0.22
-0.70%
Federated Hermes MDT Large Cap Value ETF
RSPD58.18-0.45
-0.78%
Invesco S&P 500® Equal Wt Cnsm Disc ETF
FREL26.89-0.26
-0.96%
Fidelity MSCI Real Estate ETF

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-4.63%
XNCR - CRNX
59%
Loosely correlated
-1.54%
IDYA - CRNX
52%
Loosely correlated
+3.63%
RVMD - CRNX
52%
Loosely correlated
+1.91%
CLDX - CRNX
51%
Loosely correlated
+2.70%
KURA - CRNX
51%
Loosely correlated
-0.21%
More

RNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNA has been loosely correlated with DYN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if RNA jumps, then DYN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNA
1D Price
Change %
RNA100%
+0.17%
DYN - RNA
59%
Loosely correlated
+7.01%
IDYA - RNA
48%
Loosely correlated
+4.27%
DSGN - RNA
47%
Loosely correlated
+11.90%
CRNX - RNA
44%
Loosely correlated
+16.08%
ACLX - RNA
42%
Loosely correlated
+4.75%
More